4-Fluoro-a-oxo-benzeneacetaldehyde
CAS: 403-32-7
Rif. 3D-FF23492
1g | Fuori produzione | ||
2g | Fuori produzione | ||
5g | Fuori produzione | ||
250mg | Fuori produzione | ||
500mg | Fuori produzione |
Informazioni sul prodotto
- (4-Fluorophenyl)glyoxal(p-Fluorophenyl)glyoxal2-(4-Fluorophenyl)-2-oxoacetaldehyde
- (4-Fluorophenyl)(Oxo)Acetaldehyde
- (4-Fluorophenyl)(Oxo)Acetaldehyde Hydrate
- (4-Fluorophenyl)glyoxal
- (p-Fluorophenyl)glyoxal
- 2-(4-Fluorophenyl)-2-oxoacetaldehyde
- 4-Fluoro-alpha-oxobenzeneacetaldehyde
- 4-Fluoro-α-oxobenzeneacetaldehyde
- Benzeneacetaldehyde, 4-fluoro-alpha-oxo-
- Benzeneacetaldehyde, 4-fluoro-α-oxo-
- Vedi altri sinonimi
- Brn 2354778
- Glyoxal, (p-fluorophenyl)-
- NSC 402742
- 4-07-00-02133 (Beilstein Handbook Reference)
4-Fluoro-a-oxo-benzeneacetaldehyde belongs to the class of triazolones and is a potent inhibitor of cytochrome P450 (CYP) 2C19. It has been shown that 4-fluoro-a-oxo-benzeneacetaldehyde is more potent than other compounds in this class, such as 6-(2,6-dichlorophenyl)-N-(2,2,2-trifluoroethyl)-4-(4′methylphenyl)-1,3,5 triazinone. The rat brain microsomes were used to assess the inhibitory activity of 4-fluoro-a-oxo benzeneacetaldehyde against CYP 2C19. This compound also inhibits recombinant human CYP 2C19. Treatment with 4FAA inhibited the formation of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate